The price-to-earnings ratio for Metlife Inc (NYSE: MET) is above average at 13.94x. The 36-month beta value for MET is also noteworthy at 1.03. There are mixed opinions on the stock, with 7 analysts rating it as a “buy,” 5 rating it as “overweight,” 3 rating it as “hold,” and 0 rating it as “sell.”
The public float for MET is 574.50M, and at present, short sellers hold a 1.29% of that float. The average trading volume of MET on February 11, 2025 was 3.48M shares.
MET) stock’s latest price update
The stock price of Metlife Inc (NYSE: MET) has dropped by -1.00 compared to previous close of 83.92. Despite this, the company has seen a fall of -2.82% in its stock price over the last five trading days. zacks.com reported 2025-02-06 that Management expects a variable investment income of $1.7 billion for 2025.
MET’s Market Performance
MET’s stock has fallen by -2.82% in the past week, with a monthly rise of 0.31% and a quarterly drop of -0.20%. The volatility ratio for the week is 2.28% while the volatility levels for the last 30 days are 2.05% for Metlife Inc The simple moving average for the last 20 days is -2.68% for MET’s stock, with a simple moving average of 6.62% for the last 200 days.
Analysts’ Opinion of MET
Many brokerage firms have already submitted their reports for MET stocks, with BMO Capital Markets repeating the rating for MET by listing it as a “Market Perform.” The predicted price for MET in the upcoming period, according to BMO Capital Markets is $97 based on the research report published on January 23, 2025 of the current year 2025.
TD Cowen, on the other hand, stated in their research note that they expect to see MET reach a price target of $97. The rating they have provided for MET stocks is “Buy” according to the report published on October 09th, 2024.
Barclays gave a rating of “Overweight” to MET, setting the target price at $91 in the report published on September 05th of the previous year.
MET Trading at -1.07% from the 50-Day Moving Average
After a stumble in the market that brought MET to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -6.70% of loss for the given period.
Volatility was left at 2.05%, however, over the last 30 days, the volatility rate increased by 2.28%, as shares surge +3.53% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -4.88% lower at present.
During the last 5 trading sessions, MET fell by -2.82%, which changed the moving average for the period of 200-days by +15.04% in comparison to the 20-day moving average, which settled at $85.37. In addition, Metlife Inc saw 1.47% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MET starting from MetLife Separate Account SPI, who proposed sale 957 shares at the price of $86.03 back on Jan 27 ’25. After this action, MetLife Separate Account SPI now owns shares of Metlife Inc, valued at $82,331 using the latest closing price.
Separate Account 149, the Affiliate of Metlife Inc, proposed sale 44 shares at $86.78 during a trade that took place back on Jan 21 ’25, which means that Separate Account 149 is holding shares at $3,818 based on the most recent closing price.
Stock Fundamentals for MET
Current profitability levels for the company are sitting at:
- 0.07 for the present operating margin
- 1.0 for the gross margin
The net margin for Metlife Inc stands at 0.05. The total capital return value is set at 0.01. Equity return is now at value 15.41, with 0.65 for asset returns.
Based on Metlife Inc (MET), the company’s capital structure generated 0.38 points at debt to capital in total, while cash flow to debt ratio is standing at 0.8. The debt to equity ratio resting at 0.61. The interest coverage ratio of the stock is 5.05.
Currently, EBITDA for the company is 3.92 billion with net debt to EBITDA at 2.05. When we switch over and look at the enterprise to sales, we see a ratio of 0.76. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.34.
Conclusion
In summary, Metlife Inc (MET) has had a mixed performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
